Par Drugs And Chemicals DuPont analysis

·UnclassifiedChart ›

Profitability Growth Credit Liquidity Working capital Dividend yield DuPont CAGR

Per cent unless marked ×

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

5-step DuPont — ROE = tax burden × interest burden × EBIT margin × turnover × leverage						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.76×	0.76×	0.75×	0.74×	0.75×
	1.17×	1.29×	1.13×	1.01×	1.01×
	13.6%	13.0%	15.7%	20.3%	15.6%
	0.83×	0.83×	0.91×	1.00×	1.14×
	1.16×	1.15×	1.21×	1.19×	1.25×
	11.6%	12.1%	14.5%	18.0%	16.8%
	12.4%	12.4%	14.5%	18.5%	17.3%

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

PAR₹120.70

Par Drugs And Chemicals Limited

· Unclassified

₹ CrorePeersBALAXI CROWN STEELCITY HINDCON LATTEYS HECPROJECT AIROLAM GROBTEAMcap ₹149 Cr

Profitability Growth Credit Liquidity Working Capital Yield Analysis DuPont

Ratios — % unless marked × 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
5-Step DuPont — ROE = Tax Burden × Interest Burden × EBIT Margin × Turnover × Leverage
Tax Burden (Net Income/Pretax) ×	0.75	0.74	0.75	0.76	0.76
Interest Burden (Pretax/EBIT) ×	1.01	1.01	1.13	1.29	1.17
EBIT Margin %	15.64	20.26	15.70	12.95	13.58
Asset Turnover ×	1.14	1.00	0.91	0.83	0.83
Financial Leverage (Assets/Equity) ×	1.25	1.19	1.21	1.15	1.16
ROE (5-step product, year-end total equity) %	16.83	17.99	14.52	12.11	11.64
ROE (owners' profit / average owners' equity) %	17.29	18.49	14.47	12.43	12.43

No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.